Search Results
Found 5 results
510(k) Data Aggregation
K Number
K071799Device Name
MODIFICATION TO BIOSTAR OIA SHIGATOX
Manufacturer
IVERNESS MEDICAL PROFESSIONAL DIAGNOSTICS
Date Cleared
2007-10-02
(92 days)
Product Code
GNA, GMZ
Regulation Number
866.3255Why did this record match?
Product Code :
GNA
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The BioStar® OIA® SHIGATOX assay is an Optical Immunoassay (OIA) test for the qualitative, rapid detection of the presence of Shiga toxins in human diarrheal fecal specimens, broth cultures, fecal specimens in Cary Blair Transport Media, or swab sampling of colonies from a culture plate. This test is intended for in vitro diaqnostic use as an aid in the diagnosis of infection by Shiga toxin-producing Escherichia coli (STEC) both O157 and all non - O157 Shiga toxin-producing strains.
Device Description
The OIA SHIGATOX test involves the qualitative detection of Shiga toxins 1 and 2 (Stx1 and Stx 2) produced by certain strains of Escherichia coli and other organisms. The Optical ImmunoAssay technology enables the direct visual detection of a physical change in the optical thickness of molecular thin films. This change is the result of antigen - antibody binding on an optical surface (silicon wafer). After a specimen potentially containing Shiga toxin is mixed with conjugates and placed directly on the optical surface, the immobilized surface antibodies capture the antigen/conjugate complex. After washing, the substrate is added, increasing the thickness (mass enhancement) of the molecular thin film. This change in thickness alters the reflected light path, and this alteration is visually perceived as a color change. Slight changes in the optical thickness produce a distinct visible color change. A positive result appears as a purple spot on the gold background. When antigen is not present in the specimen, no binding takes place. Therefore, the optical thickness remains unchanged, and the surface retains the original gold color indicating a negative result.
More specifically, the BioStar OIA SHIGATOX device is based on a novel thin film optical detection technology that relies on the interaction of white light with thin films to create a destructive interference phenomenon. Characteristic of this phenomenon is the generation of a reflective surface that changes color as a function of the change in optical thickness (refractive index x thickness) of the films on the surface of the device. To take advantage of this phenomenon for monitoring biological binding events, the optical surface with a special background color is coated with a capture reagent specific to the analyte of interest. In the OIA SHIGATOX device, the biological capture film is a combination of affinity-purified polyclonal antibodies to Shiga toxins 1 and 2 (Stx 1 and Stx 2). Samples suspected of containing either or both of the toxins are mixed with cocktail containing polyclonal antibodies to Stx 1 and Stx 2 that have been covalently conjugated to horseradish peroxidase (HRP). Once a sample containing toxins or either toxin is applied to the surface, the immune complex of toxin(s) and the anti-toxin-HRP conjugate(s) are bound to the surface antibodies. Following a wash step, a precipitating substrate for HRP is added, and a thin film generated by the immobilized immune complex is enhanced by the precipitation of the HRP product. Once washed and dried, a simple color change relative to the gold background color is observed as an indication of the presence of Stx 1 or Stx 2 in the original specimen.
The OIA SHIGATOX device produces a qualitative result for the presence or absence of Shiga toxin as the device output. Input to the device is the simple addition of an aliquot of fecal material (direct or in transport media) or broth culture to the reagents contained in the kit. Fecal samples are routinely collected and no special collection requirements exist. Test devices within the kit are single use devices, and disposal instructions are provided in the Package Insert. The kit contains all components necessary for analysis of the range of samples approved for use in this product, with the exception of a timer.
Ask a Question
K Number
K031367Device Name
DUOPATH VEROTOXINS GLISA TEST
Manufacturer
EMD CHEMICALS INC.
Date Cleared
2004-01-23
(268 days)
Product Code
GNA
Regulation Number
866.3255Why did this record match?
Product Code :
GNA
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Duopath® Verotoxins GLISA test is a rapid test for the qualitative identification of verotoxins Fand if (Onlya like toking) produced by E. coli isolated in cultures derived promotion aids in the diagnosis of diseases caused by enterohemorrhagic E. coli infections.
Device Description
Not Found
Ask a Question
K Number
K993401Device Name
DRYSPOT E.COLI 0157 KIT
Manufacturer
OXOID, LTD.
Date Cleared
2000-02-28
(143 days)
Product Code
GNA
Regulation Number
866.3255Why did this record match?
Product Code :
GNA
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Oxoid Dryspot E.coli 0157 test is a latex agglutination test for the identification of E.coli serogroup 0157 in colonies isolated from Sorbitol MacConkey (SMAC) Agar or SMAC Agar with Cefixime Tellurite Supplement. The test is not indicated for direct testing of faccal specimens.
Device Description
latex agglutination test
Ask a Question
K Number
K981734Device Name
VTEC-RPLA SEIKEN
Manufacturer
DENKA SEIKEN'S
Date Cleared
1998-09-22
(127 days)
Product Code
GNA
Regulation Number
866.3255Why did this record match?
Product Code :
GNA
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
VTEC-RPLA "SEIKEN" is an in vitro diagnostic device for the detection and identification of verotoxic device for in culture isolates of E. coli and is intended as an aid in the diagnosis of Enterohemorrhagic E. coli (EHEC) infections.
Device Description
VTEC-RPLA "SEIKEN" is a reagent system which can be used for the detection of verotoxins in culture isolates of E. coli to aid in the diagnosis of EHEC infections. It employs antibody-antigen reactions as part of the assay and is based on reversed passive latex agglutination (RPLA). VTEC-RPLA utilizes polyclonal antibodies specific for each verotoxin type, VT1 and VT2, and thus may be used to identify toxins.
Ask a Question
K Number
K962028Device Name
WELLCOLEX E-COLI OI57 ZC60
Manufacturer
MUREX DIAGNOSTICS, INC.
Date Cleared
1996-11-01
(162 days)
Product Code
GNA
Regulation Number
866.3255Why did this record match?
Product Code :
GNA
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Device Description
Ask a Question
Page 1 of 1